August 26, 2024 In the News MSCI Sustainability Institute, IAAMR, and FAIRR Release Health and Wealth: The Investors' Guide to AMR, A Growing Global Health Crisis Read More +
August 3, 2024 In the News Forbes: Antimicrobial Resistance On The Rise Due To Wars In Ukraine And Gaza Read More +
June 17, 2024 In the News AMR Action Fund Expands Portfolio with Investment in Elion Therapeutics Read More +
June 3, 2024 In the News Stat News Op-Ed: Antibiotic Innovation is Ailing. 'Brain Drain' May Kill It. Read More +
May 31, 2024 In the News American Chemical Society: New Antibiotics Are Hard to Come By. Red Tape is Making the Problem Worse. Read More +
May 7, 2024 In the News Los Angeles Times: A Mother's Loss Launches a Global Effort to Fight Antibiotic Resistance Read More +
April 24, 2024 In the News The New York Times: F.D.A. Approves Antibiotic for Increasingly Hard-to-Treat Urinary Tract Infections Read More +
April 24, 2024 Press Releases AMR Action Fund Portfolio Company UTILITY Therapeutics Granted FDA approval for pivmecillinam Read More +
